apoL1 Antibodies

Santa Cruz Biotechnology provides a broad selection of apoL1 monoclonal antibodies for advanced research in immunology and cell biology. apoL1 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein L1 (apoL1) plays a critical role in lipid metabolism and has been implicated in kidney function and disease, particularly in relation to hypertension and kidney injury. Research has shown that apoL1 is essential in understanding chronic kidney disease and certain forms of nephropathy, making it a significant target for therapeutic research. Understanding the function and regulation of apoL1 continues to reveal new insights into kidney health and potential treatment approaches. Researchers worldwide are actively investigating apoL1's role in various cellular pathways and disease mechanisms. Current studies focus on how apoL1 variants influence kidney disease progression and patient outcomes. The extensive selection of monoclonal antibodies from Santa Cruz Biotechnology enables researchers to advance scientific understanding of kidney disease mechanisms and potential therapeutic interventions.